留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Gut microbiota from end-stage renal disease patients disrupt gut barrier function by excessive production of phenol

Xifan Wang Yanling Hao Xiaoxue Liu Shoujuan Yu Weibo Zhang Songtao Yang Zhengquan Yu Fazheng Ren

Xifan Wang, Yanling Hao, Xiaoxue Liu, Shoujuan Yu, Weibo Zhang, Songtao Yang, Zhengquan Yu, Fazheng Ren. Gut microbiota from end-stage renal disease patients disrupt gut barrier function by excessive production of phenol[J]. Journal of Genetics and Genomics, 2019, 46(8): 409-412. doi: 10.1016/j.jgg.2019.03.015
Citation: Xifan Wang, Yanling Hao, Xiaoxue Liu, Shoujuan Yu, Weibo Zhang, Songtao Yang, Zhengquan Yu, Fazheng Ren. Gut microbiota from end-stage renal disease patients disrupt gut barrier function by excessive production of phenol[J]. Journal of Genetics and Genomics, 2019, 46(8): 409-412. doi: 10.1016/j.jgg.2019.03.015

doi: 10.1016/j.jgg.2019.03.015

Gut microbiota from end-stage renal disease patients disrupt gut barrier function by excessive production of phenol

More Information
  • [1] Al-Sadi, R., Khatib, K., Guo, S.H., Ye, D.M., Youssef, M., Ma, T., 2011. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am. J. Physiol-Gastr. L. 300, G1054-G1064.
    [2] Awad, W.A., Hess, C., Hess, M., 2017. Enteric pathogens and their toxin-induced disruption of the intestinal barrier through alteration of tight junctions in chickens. Toxins 9, 60.
    [3] Blachier, F., Mariotti, F., Huneau, J.F., Tome, D., 2007. Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 33, 547-562.
    [4] Bossola, M., Sanguinetti, M., Scribano, D., Zuppi, C., Giungi, S., Luciani, G., Torelli, R., Posteraro, B., Fadda, G., Tazza, L., 2009. Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients. Clin. J. Am. Soc. Nephro. 4, 379-385.
    [5] Cachofeiro, V., Goicochea, M., de Vinuesa, S.G., Oubina, P., Lahera, V., Luno, J., 2008. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int. 74, S4-S9.
    [6] Clemente, J.C., Ursell, L.K., Parfrey, L.W., Knight, R., 2012. The Impact of the gut microbiota on human health: an integrative view. Cell 148, 1258-1270.
    [7] Goncalves, S., Pecoits, R., Perreto, S., Barberato, S.H., Stinghen, A.E.M., Lima, E.G.A., Fuerbringer, R., Sauthier, S.M., Riella, M.C., 2006. Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol. Dial. Transpl. 21, 2788-2794.
    [8] Gonzalez, A., Krieg, R., Massey, H.D., Carl, D., Ghosh, S., Gehr, T.W.B., Ghosh, S.S., 2018. Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. Nephrol. Dial. Transplant. 34, 783-794.
    [9] Jakobsson, H.E., Rodriguez-Pineiro, A.M., Schutte, A., Ermund, A., Boysen, P., Bemark, M., Sommer, F., Backhed, F., Hansson, G.C., Johansson, M.E., 2015. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 16, 164-177.
    [10] Jiang, S., Xie, S., Lv, D., Wang, P., He, H., Zhang, T., Zhou, Y., Lin, Q., Zhou, H., Jiang, J., Nie, J., Hou, F., Chen, Y., 2017. Alteration of the gut microbiota in Chinese population with chronic kidney disease. Sci. Rep. 7, 2870.
    [11] Kanbay, M., Onal, E.M., Afsar, B., Dagel, T., Yerlikaya, A., Covic, A., Vaziri, N.D., 2018. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Int. Urol. Nephrol. 50, 1453-1466.
    [12] Karczewski, J., Troost, F.J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.J.M., Wells, J.M., 2010. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol-Gastr. L. 298, G851-G859.
    [13] Landray, M.J., Wheeler, D.C., Lip, G.Y.H., Newman, D.J., Blann, A.D., McGlynn, F.J., Ball, S., Townend, J.N., Baigent, C., 2004. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The Chronic Renal Impairment in Birmingham (CRIB) study. Am. J. Kidney Dis. 43, 244-253.
    [14] McCall, I.C., Betanzos, A., Weber, D.A., Nava, P., Miller, G.W., Parkos, C.A., 2009. Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicol. Appl. Pharm. 241, 61-70.
    [15] McDonald, T.A., Holland, N.T., Skibola, C., Duramad, P., Smith, M.T., 2001. Hypothesis: Phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia 15, 10-20.
    [16] Poesen, R., Windey, K., Neven, E., Kuypers, D., De Preter, V., Augustijns, P., D'Haese, P., Evenepoel, P., Verbeke, K., Meijers, B., 2016. The Influence of CKD on colonic microbial metabolism. J. Am. Soc. Nephrol. 27, 1389-1399.
    [17] Shimada, Y., Kinoshita, M., Harada, K., Mizutani, M., Masahata, K., Kayama, H., Takeda, K., 2013. Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS One 8. e80604
    [18] Vaziri, N.D., Duresmith, B., Miller, R., Mirahmadi, M.K., 1985. Pathology of Gastrointestinal-Tract in Chronic-Hemodialysis Patients - an Autopsy Study of 78 Cases. Am J Gastroenterol 80, 608-611.
    [19] Vaziri, N.D., Wong, J., Pahl, M., Piceno, Y.M., Yuan, J., DeSantis, T.Z., Ni, Z.M., Nguyen, T.H., Andersen, G.L., 2013. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83, 308-315.
    [20] Vaziri, N.D., Yuan, J., Rahimi, A., Ni, Z.M., Said, H., Subramanian, V.S., 2012. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol. Dial. Transpl. 27, 2686-2693.
    [21] Vaziri, N.D., Zhao, Y.Y., Pahl, M.V., 2016. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol. Dial. Transpl. 31, 737-746.
    [22] Webster, A.C., Nagler, E.V., Morton, R.L., Masson, P., 2017. Chronic kidney disease. Lancet 389, 1238-1252.
  • 加载中
计量
  • 文章访问数:  108
  • HTML全文浏览量:  42
  • PDF下载量:  4
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-01-22
  • 录用日期:  2019-03-20
  • 修回日期:  2019-03-15
  • 网络出版日期:  2019-08-02
  • 刊出日期:  2019-08-20

目录

    /

    返回文章
    返回